Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

733 ARTÍCULOS , VIENDO DEL 481 AL 495

The glymphatic system as a brain scavenger in Alzheimer's disease: mechanisms and therapeutic implications

Zheng M, Su W, Tian L, Gao W.

Brain Res. 2026 Jun 1;1880:150221. doi: 10.1016/j.brainres.2026.150221. Epub 2026 Feb 26.

PANoptosis in Alzheimer's disease: The expanding landscape of programmed cell death mechanisms and therapeutic interventions

Paidlewar M, Kumari S, Dhapola R, Sharma P, Vellingiri B, Medhi B, HariKrishnaReddy D.

Free Radic Biol Med. 2026 Jul;250:80-98. doi: 10.1016/j.freeradbiomed.2026.03.053. Epub 2026 Mar 20.

Targeting Lipid Metabolism in Alzheimer's Disease: Emerging Insights and Future Directions

Balakrishnan J, Kannan S, Shanmugam K, Sugasini D.

J Integr Neurosci. 2026 Apr 21;25(4):48436. doi: 10.31083/JIN48436.

Protein Modifications and Quality Control System: Target for Alzheimer's Disease Therapy

Sheikh AM, Yano S, Tabassum S, Bhuiya J, Nagai A.

Int J Mol Sci. 2026 May 11;27(10):4266. doi: 10.3390/ijms27104266.

Effect of Physical Activity on Cognitive Function of Patients With Alzheimer's Disease: A Meta-analysis

Dai S, Yuan S, Zhang X, Zhong X, Jiang C.

J Integr Neurosci. 2026 Jan 26;25(1):42702. doi: 10.31083/JIN42702.

Lecanemab and Donanemab Combination Therapy for Alzheimer's Disease-The Cocktail May Work Even Better Together

Dinnerstein E.

Alzheimer Dis Assoc Disord. 2026 Jan-Mar 01;40(1):65-66. doi: 10.1097/WAD.0000000000000711. Epub 2026 Feb 24.

Cost-effectiveness of traditional and novel neurotherapeutic agents for Alzheimer's disease: A systematic review

Jiang X, Lv G, Xiong X, Yuan J, Kevin Lu Z.

J Alzheimers Dis. 2026 May;111(1):102-114. doi: 10.1177/13872877261430376. Epub 2026 Mar 16.

Targeting STAT3 in Alzheimer's disease: Potential mechanisms and therapeutic implications

Chen P, Wang R, Zhou T, Sun Y, Kirchhoff F, Miao Z, Zhuang C.

Eur J Med Chem. 2026 Jun 5;310:118785. doi: 10.1016/j.ejmech.2026.118785. Epub 2026 Mar 18.

Efficacy, safety, and ARIA risk of anti-β-amyloid antibodies in early Alzheimer's disease: a systematic review, meta-analysis, and meta-regression

da Silva AMP, de Deus O, Januário Campos Cardoso L, Virgilio Ribeiro F, Froelich Meldola P, Rodrigues Menezes I, Lee Han M, Quiroga DG, James Almeida K, Haddad Santos D, Perry G, Høilund-Carlsen PF, de Souza Franco E, de Sousa Maia MB.

Expert Opin Biol Ther. 2026 Jan-Feb;26(2):177-188. doi: 10.1080/14712598.2026.2631536. Epub 2026 Feb 14.

Tau phosphorylation homeostasis: Mechanisms, targets, and therapeutic implications in Alzheimer's disease

Lu S, Qiu S, Guan Y, Zhang A, Zhao Q.

Ageing Res Rev. 2026 Jun;118:103097. doi: 10.1016/j.arr.2026.103097. Epub 2026 Mar 18.

Hallucinogenic Therapy in Alzheimer's Disease targeting Mitochondria-Associated Membranes

Minauro-Sanmiguel F, Vargas-Perez H.

Neuroscience. 2026 Apr 6;599:162-169. doi: 10.1016/j.neuroscience.2026.02.028. Epub 2026 Feb 16.

Brain peptides in Alzheimer's disease - pathophysiology and therapeutic advances

Pahal S, Gupta A, Kumar V, Singh P, Kaushik M, Pahal V, Atluri G, Chaudhary A.

Cell Tissue Res. 2026 Mar 3;403(3):28. doi: 10.1007/s00441-026-04055-8.

Drug repurposing in Alzheimer's disease: Emerging therapeutic strategies and promising candidates

More PS, Rangari SW, Lade SN, Unidrwade DS, Burle SS, Umekar MJ, Lohiya RT, Zanwar AS.

Ageing Res Rev. 2026 Jun;118:103113. doi: 10.1016/j.arr.2026.103113. Epub 2026 Apr 7.

Traditional Chinese Medicine and Ferroptosis in Alzheimer's Disease: A Potential Therapeutic Approach

Liu A, Xing L, Li J, Yao M, Song J, Guo W, Duan P, Li H.

Drug Des Devel Ther. 2026 Mar 9;20:590868. doi: 10.2147/DDDT.S590868. eCollection 2026.

[New therapies and ongoing clinical trials in Alzheimer's disease]

Andersen P, Bonnard A, Börjesson Hanson A, Kivipelto M.

Lakartidningen. 2026 May 20;123:25147.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias